whole-genome sequencing
GeneDx to Offer Genome Interpretation as a Standalone Service Following Fabric Genomics Acquisition
Premium
GeneDx, which has been running a centralized lab, hopes to provide the new service to hospitals in the US and abroad that are already sequencing genomes in-house.
GeneDx to Acquire Fabric Genomics in Deal Potentially Worth $51M
The acquisition is expected to close in Q2, and GeneDx could pay up to $51 million for Fabric upon achievement of certain milestones.
The company welcomed favorable results last week from a study comparing its test to a narrower ddPCR-based approach in patients from an ongoing interventional trial.
Inclusive Newborn Sequencing Approach Shows Potential for Boosting Diagnostic Rate
Researchers increased the diagnostic rate for critically ill newborns by using simple, broad exclusion criteria rather than complicated guidelines for selecting infants to be sequenced.
The clinical genetic testing company's Q4 revenues jumped 64 percent year over year to $95.6 million, driven by its strong exome and whole-genome testing business.